Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
This study has been completed.
Sponsor:
Sarah Cannon Research Institute
Collaborators:
GlaxoSmithKline
Eli Lilly and Company
Information provided by:
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT00315861
First received: April 17, 2006
Last updated: January 22, 2009
Last verified: January 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2009 |
| Primary Completion Date: | May 2008 (Final data collection date for primary outcome measure) |